LONGEVITY IS NOW A FACTOR WHEN PICKING AN EMBRYO FOR IVF

Summary from the TLDR newsletter

Nucleus Genomics is a DNA testing and analysis company that plans to provide DNA testing for embryos to predict and reduce chronic diseases. It will analyze up to 20 embryos for $5,999, providing an analysis of up to 900 conditions. The embryos will be given probabilities for the likelihood they will get these chronic conditions and then it will be up to the parents to decide which embryos to use. Nucleus also provides possibility assessments for attributes such as IQ, height, and eye color.